Advanced Medical Solutions (AQA) Stock Statistics & Valuation Metrics
Total Valuation
Advanced Medical Solutions has a market cap or net worth of EUR 732.67M. The enterprise value is EUR 680.02M.
- Market Cap
- EUR 732.67M
- Enterprise Value
- EUR 680.02M
Share Statistics
Advanced Medical Solutions has 219,604,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 219,604,170
- Owned by Insiders
- ―
- Owned by Institutions
- 4.54%
Financial Efficiency
Advanced Medical Solutions’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.47%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 3.47%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 127.19K
- Profits Per Employee
- 5,530
- Employee Count
- 1,800
- Asset Turnover
- 0.58
- Inventory Turnover
- 1.72
Valuation Ratios
The current PE Ratio of Advanced Medical Solutions is 166.18. Advanced Medical Solutions’s PEG ratio is -2.78.
- PE Ratio
- 166.18
- PS Ratio
- 2.62
- PB Ratio
- 2.41
- Price to FCF
- 76.90
- Price to Operating Cash Flow
- 30.05
- PEG Ratio
- -2.78
Income Statement
In the last 12 months, Advanced Medical Solutions had revenue of 228.94M and earned 9.95M in profits. Earnings per share was 0.05.
- Revenue
- 228.94M
- Gross Profit
- 108.78M
- Operating Income
- 21.99M
- Pretax Income
- 17.78M
- Net Income
- 9.95M
- EBITDA
- 43.39M
- Earnings Per Share (EPS)
- 0.05
Cash Flow
In the last 12 months, operating cash flow was 20.38M and capital expenditures -12.43M, giving a free cash flow of 7.95M billion.
- Operating Cash Flow
- 20.38M
- Free Cash Flow
- 7.95M
- Free Cash Flow per Share
- 0.04
Dividends & Yields
Advanced Medical Solutions pays an annual dividend of ―, resulting in a dividend yield of 1.56%
- Dividend Per Share
- ―
- Dividend Yield
- 1.56%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.30%
- Earnings Yield
- 0.60%
Stock Price Statistics
- Beta
- 0.41
- 52-Week Price Change
- 38.84%
- 50-Day Moving Average
- 3.28
- 200-Day Moving Average
- 2.83
- Relative Strength Index (RSI)
- 59.02
- Average Volume (3m)
- 798
Important Dates
Advanced Medical Solutions upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 16, 2026
- Next Earnings Date
- Mar 17, 2027
- Ex-Dividend Date
- ―
Financial Position
Advanced Medical Solutions as a current ratio of 2.79, with Debt / Equity ratio of 31.50%
- Current Ratio
- 2.79
- Quick Ratio
- 1.39
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- 1.46
- Interest Coverage Ratio
- 4.32
Taxes
In the past 12 months, Advanced Medical Solutions has paid 7.69M in taxes.
- Income Tax
- 7.69M
- Effective Tax Rate
- 0.43
Enterprise Valuation
Advanced Medical Solutions EV to EBITDA ratio is 14.14, with an EV/FCF ratio of 85.93.
- EV to Sales
- 2.92
- EV to EBITDA
- 14.14
- EV to Free Cash Flow
- 85.93
- EV to Operating Cash Flow
- 33.52
Balance Sheet
Advanced Medical Solutions has EUR 13.56M in cash and marketable securities with EUR 85.37M in debt, giving a net cash position of -EUR 71.81M billion.
- Cash & Marketable Securities
- EUR 13.56M
- Total Debt
- EUR 85.37M
- Net Cash
- -EUR 71.81M
- Net Cash Per Share
- -EUR 0.33
- Tangible Book Value Per Share
- EUR 0.27
Margins
Gross margin is 47.94%, with operating margin of 11.29%, and net profit margin of 1.58%.
- Gross Margin
- 47.94%
- Operating Margin
- 11.29%
- Pretax Margin
- 4.13%
- Net Profit Margin
- 1.58%
- EBITDA Margin
- 20.67%
- EBIT Margin
- 11.29%
Analyst Forecast
The average price target for Advanced Medical Solutions is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.56%
- EPS Growth Forecast
- -61.19%
Scores
- Smart Score
- 5
- AI Score
- ―
